Corrigendum to: Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

Kristensen, Steen Dalby; Laut, Kristina Grønborg; Fajadet, Jean; Kaifoszova, Zuzana; Kala, Petr; Mario, Carlo Di; Wijns, William; Clemmensen, Peter; Agladze, Vaja; Antoniades, Loizos; Alhabib, Khalid F; Boer, Menko‐Jan de; Claeys, Marc J.; Deleanu, Dan; Dudek, Dariusz; Ērglis, Andrejs; Gilard, Martine; Göktekín, Ömer; Guagliumi, Giulio; Guðnason, Þórarinn; Hansen, Kim Wadt; Huber, Kurt; James, Stefan; Janota, Tomáš; Jennings, Siobhán; Kajander, Olli A.; Kanakakis, John; Karamfiloff, Kiril; Kedev, Saško; Kornowski, Ran; Ludman, Peter; Merkely, Béla; Miličić, Davor; Najafov, Ruslan; Nicolini, Fabio; Nočc, Marko; Ostojic, Miodrag; Pereira, H; Radovanović, Dragana; Sabaté, Manel; Sobhy, Mohamed; Sokolov, М. Yu.; Studenčan, Martin; Terzić, Ibrahim; Wahler, S; Widimský, Petr

doi:10.1093/eurheartj/ehu333

Cited by 24 publications

(20 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Nonetheless, in-hospital mortality for ACS patients due to UMLCA occlusion or subocclusion vastly exceed the 4%-12% mortality in unselected STEMI patients observed in national registries from ESC countries. 19 In-hospital mortality (15%) and overall mortality (47%) are high.…”

Section: Discussionmentioning

confidence: 99%

Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis

Dürig

Arroyo

Bédossa

et al. 2023

Cathet Cardio Intervent

View full text Add to dashboard Cite

Aims Unprotected left main coronary artery (ULMCA) occlusion is a rare and disastrous condition with scarce data on presentation and outcomes. Herein, we report data on patients presenting with acute coronary syndrome due to ULMCA occlusion at four different institutions. Methods This is an international multicentre observational study. Baseline characteristics were retro‐ and prospectively collected. Clinical follow‐up was prospective. The primary outcome was in‐hospital death. Patients surviving the index hospitalization were compared with nonsurvivors to find predictors of survival. Results The study population consisted of 55 patients. Eight patients (15%) died in the cath lab, and 23 (42%) died in hospital. Three (6%) deaths were noncardiac and due to major bleeding. Thirty‐two (58%) patients survived the index hospitalization and were discharged. These patients were followed for a median of 17.5 months during which three cardiac deaths occurred. Repeat revascularization was performed in 25% (n = 8). Overall mortality at maximum follow‐up was 47% (n = 26). The only significant predictor for hospital survival was left ventricular ejection fraction (odds ratio [OR]: 1.10 (per 1 point increase); 95% confidence interval [CI]: 1.02–1.19; p = 0.02). Conclusion ULMCA occlusion carries a high short‐term mortality. Patients who survive index hospitalization have similar mortality rates as compared with other st elevation myocardial infarction patients.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis

Dürig

Arroyo

Bédossa

et al. 2023

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…Um registro realizado pela Sociedade Europeia de Cardiologia, incluindo países, mostrou mortalidade intrahospitalar variando de 3,1% a 6,1%. 10 Um ensaio francês, executado entre os anos de 1995 a 2010, constatou uma queda na mortalidade em 30 dias de 13,7% para 4,4%. Esse decréscimo se deve a múltiplos fatores dentro da assistência ao paciente com IAMcSST, como o aumento na quantidade de unidades de terapia intensiva móveis, aumento no número de campanhas públicas informativas a respeito dos sintomas relacionados ao agravo e menor atraso tanto na chegada em hospital capacitado, quanto na decisão de procurar socorro.…”

Section: Discussionunclassified

Influência da Localização Geográfica no Acesso às Terapias de Reperfusão e Mortalidade de Pacientes com IAMcSST em Sergipe: Registro VICTIM

Oliveira¹,

Ferreira²,

Oliveira³

et al. 2021

Arquivos Brasileiros De Cardiologia

View full text Add to dashboard Cite

Fundamento: A concentração de serviços de alta complexidade em Aracaju/SE pode proporcionar disparidade na qualidade assistencial para os pacientes do SUS com infarto agudo do miocárdio com supradesnivelamento do segmento ST (IAMcSST) cujos sintomas se iniciaram em outras regiões de saúde do estado.Objetivo: Avaliar disparidades no acesso às terapias de reperfusão e mortalidade em 30 dias, entre pacientes com IAMcSST, usuários do SUS, em cada uma das 7 regiões de saúde em Sergipe. Métodos: Foram avaliados 844 pacientes com IAMcSST no período de 2014 a 2018 atendidos pelo único hospital com capacidade de ofertar intervenção coronariana percutânea (ICP) primária para usuários do SUS no estado de Sergipe. Os pacientes foram divididos em 7 grupos de acordo com o local de início dos sintomas e obedecendo a divisão já existente das regiões de saúde do Estado. Para comparação entre grupos, foi considerada diferença significativa quando p < 0,05. Resultados: Do total de 844 pacientes vítimas de IAMcSST e transferidos ao hospital com ICP que atende pacientes do SUS, 386 pacientes (45,8%) realizaram angioplastia primária. A taxa média do uso de fibrinolítico foi de 2,6%, não havendo diferenças entre as regiões. O tempo médio total de chegada ao hospital com ICP foi de 21h55' com mediana de 10h22' (6h30' -22h52'). A mortalidade total em 30 dias foi 12,8%, mas sem diferenças entre as regiões, mesmo quando ajustada para idade e sexo. Conclusões: Este estudo revela que os fibrinolíticos são subutilizados em todo o estado e que existe um atraso significativo no acesso ao hospital com ICP, em todas as regiões de saúde de Sergipe.

show abstract

“…Further interventional measures are required in order to prevent CAD from developing into an epidemic, for instance, a national prevention program offered for high-risk populations to reduce modifiable risks [4]. Although the rate of percutaneous coronary intervention (PCI) with ST-elevation myocardial infarction (STEMI) in Saudi Arabia has increased significantly in the previous years, the rate of PCIs (23 per 1,000,000) was compared to the rate of thrombolytic therapy (161 per 1,000,000) in 2011, which might be attributed to the presence of only four hospitals with 24/7 primary PCI service across the country [5].…”

Section: Introductionmentioning

confidence: 99%

The Impact of the COVID-19 Pandemic on Coronary Interventional Cardiology Activity in King Abdulaziz Medical City: A Retrospective Study

AlBattal¹,

AlShebel²,

Balgaith³

et al. 2023

Cureus

View full text Add to dashboard Cite

Background: The COVID-19 pandemic has decreased the number of patients undergoing coronary interventional procedures. This study aimed to identify the impact of the COVID-19 pandemic on the volume of patients and the types of interventional cardiology procedures performed at King Abdulaziz Cardiac Center (KACC) in Riyadh, Saudi Arabia.Methods: A retrospective chart review was undertaken with a sample size of 301 patients aged over 18 years, who underwent various cardiac interventions at King Abdulaziz Cardiac Center (KACC) between March 15, 2019, and February 29, 2020 (prior to the pandemic, group A), and between March 1, 2020, and March 15, 2021 (during the pandemic, group B). The BESTCare 2.0 system (ezCaretech, Seoul, South Korea) was used to collect data, Microsoft Office Excel (Microsoft ® Corp., Redmond, WA) was utilized for data entry, and the Statistical Package for Social Sciences software (IBM SPSS Statistics, Armonk, NY) was employed for data analysis.Results: There was a 21.4% decrease in the number of procedures performed during the pandemic. The largest age group within the population was ≥60 years, comprising 43.5% and 52.3% of groups A and B, respectively. Most patients had a body mass index (BMI) of >30, i.e., 43.5% of patients before the pandemic and 47.7% after the pandemic. In group A, 39.9% were smokers and 60.6% in group B. The prevalence of hypertension and obesity was higher in group B, i.e., 77.3% and 42.3%, respectively. The incidence of STelevation myocardial infarction (STEMI) was 39.9% in group A and 39.4% in group B. For non-ST-elevation myocardial infarction (NSTEMI), the comparable statistics were 56.5% and 49.2%, respectively. In groups A and B, readmission frequencies were 17.9% and 20%, respectively. Conclusion:The study indicates a minor decline in the number of percutaneous coronary interventions (PCIs) conducted in the interventional cardiology department of King Abdulaziz Cardiac Center (KACC) immediately following the COVID-19 outbreak, reflecting a steady activity in the center.

show abstract

Corrigendum to: Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

Cited by 24 publications

References 0 publications

Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis

Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis

Influência da Localização Geográfica no Acesso às Terapias de Reperfusão e Mortalidade de Pacientes com IAMcSST em Sergipe: Registro VICTIM

The Impact of the COVID-19 Pandemic on Coronary Interventional Cardiology Activity in King Abdulaziz Medical City: A Retrospective Study

Contact Info

Product

Resources

About